1. Delivery Strategies for Melittin-Based Cancer Therapy
   Jie Zhou et al, 2021, ACS Applied Materials & Interfaces CrossRef
2. The membrane effects of melittin on gastric and colorectal cancer
   Caroline Soliman et al, 2019, PLOS ONE CrossRef
3. Melittin-MIL-2 fusion protein as a candidate for cancer immunotherapy
   Mingjun Liu et al, 2016, Journal of Translational Medicine CrossRef
4. Immunomodulatory activities and biomedical applications of melittin and its recent advances
   Zohreh Jafari et al, 2024, Archiv der Pharmazie CrossRef
5. Functional characterization and development of novel human kinase insert domain receptor chimeric antigen receptor T-cells for immunotherapy of non-small cell lung cancer
   Ming Zhong et al, 2023, European Journal of Pharmaceutical Sciences CrossRef
6. Hosts and Heterologous Expression Strategies of Recombinant Toxins for Therapeutic Purposes
   Luana di Leandro et al, 2023, Toxins CrossRef
7. Melittin inhibits tumor growth and decreases resistance to gemcitabine by downregulating cholesterol pathway gene CLU in pancreatic ductal adenocarcinoma
   Xinjing Wang et al, 2017, Cancer Letters CrossRef
8. Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy
   Islam Rady et al, 2017, Cancer Letters CrossRef
9. Recent developments in animal venom peptide nanotherapeutics with improved selectivity for cancer cells
   Julien Giribaldi et al, 2021, Biotechnology Advances CrossRef
10. Cancer nanomedicine: from PDGF targeted drug delivery
    Chandrababu Rejeeth et al, 2017, MedChemComm CrossRef
11. Application of bee venom and its main constituent melittin for cancer treatment
    Cui-cui Liu et al, 2016, Cancer Chemotherapy and Pharmacology CrossRef
12. Expression of novel lhmlt fusion protein using plant viral vector and study of its anticancer effect
    Zahid Naseri et al, 2020, Plant Cell, Tissue and Organ Culture (PCTOC) CrossRef
13. Bee venom: A medical perspective
    Ali Korhan SİG et al, 2019, Turkish Journal of Clinics and Laboratory CrossRef
14. Recent advances in melittin-based nanoparticles for antitumor treatment: from mechanisms to targeted delivery strategies
    Xiang Yu et al, 2023, Journal of Nanobiotechnology CrossRef